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and  Mary E.  Brindle ,  MD ,  MPH 
 BACKGROUND:  Patent ductus arteriosus (PDA) in the nonpremature pediatric patient is cur-
rently treated by surgical ligation or catheter occlusion. Th ere is no clear superiority of one 
technique over the other. Th is meta-analysis compares the clinical outcomes of the two treat-
ment options for PDA. 
 METHODS:  We performed a literature search of MEDLINE, Embase, PubMed, and the 
Cochrane database of randomized controlled trials (RCTs) that took place between 1950 and 
February 2014 and hand-searched references from included studies. We excluded studies 
of adult or premature patients and those without a direct comparison between surgical and 
catheter-based treatments of PDAs. Outcomes of interest were reintervention, total complica-
tions, length of stay, and cost. 
 RESULTS:  One thousand three hundred thirty-three manuscripts were screened. Eight 
studies fulfi lled the inclusion criteria (one RCT and seven observational studies [N  5 1,107]). 
In pooled observational studies, there were signifi cantly decreased odds (OR, 0.12; 95% CI, 
0.03-0.42) for reintervention in the surgical ligation group but insignifi cantly higher odds for 
overall complications (OR, 2.01; 95% CI, 0.68-5.91). Th ere were no complications reported in 
the RCT, but surgical ligation was associated with decreased odds for reintervention and a 
longer length of stay. Funnel plots revealed a possible publication bias and a quality review 
identifi ed comparability bias. 
 CONCLUSIONS:  Both therapies have comparable outcomes. Reintervention is more common 
with catheter-based treatment, but overall complication rates are not higher and hospital stay 
is shorter. Our data span  . 2 decades and may not refl ect current surgical and catheterization 
outcomes. Large, randomized, prospective studies may help determine the optimal treatment 
strategy.  CHEST 2015;  148 ( 3 ): 784 - 793 
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 Patent ductus arteriosus (PDA) is one of the most 
common congenital heart diseases. 1 Although small 
PDAs may be asymptomatic, larger ones can result in 
clinically significant complications. 1 PDAs that are 
large, symptomatic, or persistent despite medical 
therapy require procedural intervention. Th oracotomy 
has remained the standard for treating PDAs since it 
was fi rst performed in 1938. 2,3 
 In recent years, minimally invasive methods to oblit-
erate PDA have been developed. Video-assisted thora-
coscopic surgery (VATS) was applied to the treatment 
of PDAs in 1991. 4 Cardiac catheterization, fi rst used to 
treat PDAs in 1966, 5 now delivers a variety of devices 
for PDA occlusion. 6-9 Few have studied these devices 
in comparison with surgical ligation. Although pre-
term infants are too small for the use of transcatheter 
approaches, controversy remains as to which manage-
ment option is optimal for the rest of the pediatric pop-
ulation. In this systematic review, we examine all studies 
with direct comparisons between surgical ligation and 
transcatheter approaches for PDA closure in nonprema-
ture children. 
 Materials and Methods 
 We followed the guidelines outlined by the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) statement 10 
( e-Appendix 1 ). The meta-analysis was performed using the meth-
odology suggested by the Meta-analysis of Observational Studies in 
Epidemiology (MOOSE) group. 11 
 We performed a systematic search of all articles from 1950 to February 
20, 2014, in MEDLINE, Embase, PubMed, and the Cochrane Central 
Register of Controlled Trials. Our search strategy included the terms 
Pediatr* OR child* OR neonate* OR infant AND PDA OR patent ductus 
AND Trans-catheter OR occlusion OR coil* OR clip OR radiologic OR 
interventional OR device OR surgery OR ligation OR suture including 
MeSH headings of patent ductus and surgery. Th e full search strategy 
can be seen in  e-Appendix 2 . A hand search of references from included 
studies was performed to identify additional publications. No language 
restrictions were placed, and non-English papers were translated. Th e 
authors attempted to contact authors to retrieve missing data when 
necessary to determine whether the article met the inclusion/exclusion 
criteria or for data abstraction. 
 Study titles, abstracts, and full articles were reviewed independently by 
two authors (J. Y. L. and M. E. B.) for inclusion. Disagreements were 
resolved by consensus. Studies were included if there was a direct 
comparison between surgical ligation and catheter-based therapies for 
PDAs in the pediatric population. Studies were excluded if they had 
fewer than four subjects or if they examined preterm infants or adult 
patients without a population of nonpremature pediatric patients that 
could be analyzed separately. Studies were also excluded if they con-
tained duplicate or nonoriginal data, animal subjects, a lack of direct 
comparison between the interventions, or an absence of clinical out-
comes, or if separate/missing data were not available despite attempts 
to contact authors. All comparative study designs were considered. 
 Th e primary outcome of interest was residual or recurrent PDA requir-
ing repeat intervention. Secondary outcome measures included com-
plications, hospital length of stay (LOS), length of procedure, and 
cost of intervention. We converted reported costs into United States 
dollars using historical exchange rates. 12 Because the studies spanned 
a number of years, we used the exchange rate on the median date of 
data collection. 
 Two reviewers (J. Y. L. and M. E. B.) independently extracted data using 
a standardized form ( e-Appendix 3 ). Data collected included publica-
tion date, country and institute where the study was performed, dates 
of data collection, study design, number of cases, intervention type, age 
of the patients, and size of the PDAs, as well as data on primary and 
secondary outcomes. Th ree reviewers (J. Y. L., S. R. L., and M. E. B.) 
analyzed the design and methodologic quality of included studies using 
the Newcastle-Ottawa Quality Assessment Scale for cohort studies and 
the Jadad scale for reporting randomized controlled trials (RCTs) to 
evaluate for the risk of bias. 13,14 
 Agreement in title, abstract, and article inclusion was reported using 
Cohen’s  k statistic. For outcome measures, ORs of observational studies 
were pooled for both total complication rates and reintervention rates 
using a random eff ects model. 
 Publication bias was assessed by inspecting for asymmetry in the Begg’s 
funnel plots and by performing Egger’s test for publication bias. All 
analyses were performed using Stata 13 (StataCorp LP).  
 Results 
 Th e electronic search yielded 1,333 articles. Aft er dupli-
cates were removed, 711 studies remained ( Fig 1 ). We 
excluded 638 papers based on review of titles, and an 
additional 54 papers on review of abstracts ( k  5 0.86 
and 0.83, respectively). An additional fi ve studies were 
identified based on a hand search of included study 
references, resulting in a total of 24 studies. Th e full texts 
of these articles were evaluated in detail, and 16 studies 
were excluded ( k  5 1). Eight studies met the inclusion 
criteria and were included in the analysis (one RCT 
and seven observational cohort studies), for a total of 
1,107 children ( Fig 1 ). 15-22 
 Study characteristics are summarized in  Table 1 . We 
identified one RCT performed at a single center in 
Vietnam. 22 In this study, 100 patients were randomized 
equally to either VATS surgical ligation or catheter-based 
treatment with either the Amplatzer occluder or fl ipper 
coils based on PDA size. In the seven observational 
cohort studies, 1,007 children were treated for PDA. 15-21 
Of these, 590 children underwent surgical ligation (65 by 
VATS and 525 by thoracotomy), whereas 417 children 
were treated with catheter-based therapy (192 with 
Gianturco coils, 20 with Amplatzer occluders, and 205 
with the Rashkind double-umbrella system). Patient age 
ranged from a few days of age to 18 years. All studies 
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 Figure 1 – Flow diagram of study identifi cation, inclusion, and 
exclusion.  k agreement between reviewers (J. Y. L. and M. E. B.). 
excluded patients with other signifi cant comorbidities/
cardiac anomalies. 
 In the RCT, randomization was completed using shuffl  ed 
sealed envelopes. No attempt was made at blinding, and 
all patients were accounted for in follow-up. 
 Of the observational studies, only one study by Dutta et al 20 
had appropriate comparability between interventions, 
matching patients by age, sex, weight, and PDA diameter. 
Four studies reported adequate accountability of their 
patients in follow-up and adequate follow-up strategy 
using echocardiography to document residual or 
recurrent PDA, 18-21 whereas fi ve studies had adequate 
follow-up length. 17-21 Th e two multicenter studies lost 
points for drawing patients treated with catheter-based 
therapy from a diff erent community than that of the 
surgically treated group ( Table 2 ). 15,20 No studies attempted 
to control for confounding through regression analyses, 
although stratifi cation was performed in the study by 
Dutta et al. 20 
 Evidence of publication bias was present in these studies. 
Asymmetry was apparent in Begg’s funnel plots for 
both reintervention and total complications. For reinter-
vention, Egger’s test shows signifi cant publication bias 
for reintervention (0.05) but not for complication rates 
(0.11). 
 In the observational studies, two of the 590 patients in 
the surgical ligation group required reintervention for 
persistent/recurrent PDA, one originally treated by 
VATS approach and one by thoracotomy; 32 of the 
417 patients in the catheter-based group required 
reintervention, 20 of the 205 with the Rashkind double-
umbrella system (9.8%), and 12 of the 192 with Gianturco 
coils (6.3%). Two studies reported no reintervention in 
patients treated with either surgical ligation or catheter-
based therapy. 20,21 In a pooled analysis of the observational 
studies, decreased odds of reintervention was associated 
with surgical ligation compared with catheter-based 
therapy for PDA (OR, 0.12; 95% CI, 0.03-0.42;  P  5 .001). 
These studies demonstrated low heterogeneity, with 
an  I 2 of 14.4% ( P  5 .32) ( Fig 2 ). In the RCT, no patients 
in the surgical arm required reintervention, compared 
with three patients in the catheter-based treatment 
arm. 22 
 Complications were defi ned as any clinically important 
complication directly related to the procedure itself. 
Examples for the surgery group included recurrent 
laryngeal nerve injury, need for chest tube (chylothorax, 
pneumothorax, or other), and diaphragmatic paralysis. 
Catheter-based complications included embolization 
with further complications (beyond reintervention) and 
vascular injuries. Need for transfusion and infection 
were reported in both groups. 
 In the observational studies, complications occurred in 
85 of 590 patients in the surgical treatment arm and 
44 of 417 patients treated with catheter-based therapy. 
In pooled analysis, there was a nonsignifi cant increase 
in the odds of complications associated with surgical 
therapy (OR, 2.01; 95% CI, 0.68-5.91;  P  5 .21). Th ere 
was moderate heterogeneity in these studies, with an  I 2 
of 54.6% ( P  5 .066) ( Fig 3 ). In the RCT, no complica-
tions were seen in either treatment group. 22 
 Of the observational studies, six reported LOS. 15,16,18-21 
As with the RCT, in the observational studies, surgical 
patients had a longer LOS ( Table 3 ). 
 Four of the eight studies reported the procedure time 
for both interventions. In two studies, the total operative 
time for surgical ligation exceeded the total procedural 
time for catheter-based therapy. 20,22 In the other two 
studies, the opposite was true. 15,18 In both studies in 
which surgical ligation time exceeded catheter procedural 
time, surgical ligation was performed using a VATS 
approach ( Table 3 ). 
 In seven studies, costs were estimated for both inter-
ventions. There was a great deal of variability in the 
results. Three studies showed increased costs with 
surgery, 17,20,21 whereas two studies reported greater 
costs with catheter-based approaches. 15,22 Two studies 
showed almost no diff erence in cost between the two 
interventions ( Table 4 ). 16,18 All studies reported the cost 
of providing treatment as opposed to prices charged 
for services. 
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 Two of the observational studies examined patients 
treated with VATS. 19,20 In total, 65 patients were treated 
by VATS, with one requiring reintervention; nine of 
the 147 patients treated with catheter-based therapy 
required reintervention. Th ree of the 65 patients treated 
with VATS had documented complications, compared 
with one patient in the catheter-based therapy cohort. 
 Discussion 
 Surgical ligation of PDA among children and infants 
of  . 37 weeks’ gestation resulted in lower rates of rein-
tervention compared with catheter-based techniques. 
Although each intervention was associated with a 
diff erent spectrum of complications, surgery had a non-
signifi cant tendency toward higher complication rates. 
Surgery also had a longer LOS, whereas cost and proce-
dural times were variable. 
 In the single RCT examined, patients in the surgery arm 
did not require reintervention, whereas 6% required 
reintervention in the catheter arm. Th is reintervention 
rate is higher than that described in large case series 
examining the effi  cacy of the Amplatzer occluder. 23-26 
The higher reintervention rate for catheter-based 
therapy in the RCT is echoed in the pooled analysis of 
 Figure 2 – Forest plot of impact of treatment on need for reintervention. 
 Figure 3 – Forest plot of impact of treatment on complications. 
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observational studies in which surgical therapy had 
signifi cantly decreased odds of requiring reintervention 
(pooled OR, 0.12; 95% CI, 0.03-0.42). Complication rates 
are low for both surgery and interventional approaches 
to PDAs. No complications were reported in either arm 
of the RCT, and in the pooled results of observational 
studies, surgery had an increased risk of complications 
compared with catheter-based therapies (pooled OR, 
2.01; 95% CI, 0.68-5.91). This is a nonsignificant 
result, but the small numbers leave this fi nding prone 
to type 2 error. Th e studies in our meta-analysis are pri-
marily observational studies with the risks of selection 
bias and publication biases. 
 Th e success of PDA closure via catheter-based intervention 
is associated with PDA size and morphology. 27,28 Larger 
PDAs oft en require more coils or alternative devices; 
subsequently, it is more diffi  cult to achieve complete 
closure. Many studies in this review did not include 
information on the size or morphology of the PDA, nor 
was consistent information provided in terms of the 
number of devices used or the decision-making around 
device selection. 
 Surgical ligation is more eff ective in closing PDAs but 
may be associated with an increased risk of complications. 
For subjects undergoing the VATS approach, 4.6% had 
complications, compared with 0.7% of patients treated 
with catheter-based therapy. Th e safety and effi  cacy of 
VATS is reported in a number of studies. 29-31 In a large 
case series of pediatric patients with PDA treated by 
VATS, patients suff ered no mortality and low morbidity 
with 1.3% residual patency. 29 Another study from 2011 
compared pediatric patients with PDA treated by either 
VATS or thoracotomy. No patients required reinterven-
tion, but VATS had fewer complications, a lower cost, a 
shorter LOS, and a shorter time in the operating room . 32 
Th e same authors also compared the outcomes of pedi-
atric and adult PDAs treated either by VATS or by 
catheter-based therapy using the Amplatzer occluder 
and found that subjects undergoing VATS did not 
require reintervention compared with 4.1% in the 
catheter arm. VATS also had fewer complications and a 
lower cost but an increased duration of procedure and a 
longer LOS. 33 
 Th e variability in cost comparisons is likely multifacto-
rial. Costs vary based on treatment location even when 
controlling for currency. In addition, diff erent studies 
include diff erent items in their cost analysis. Given these 
factors, it is diffi  cult to comment on which treatment 
strategy is more cost eff ective. Other studies comparing 
the cost of surgical and catheter-based therapies in 
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adult and pediatric patients have demonstrated similar 
inconsistencies. 34,35 
 As with all meta-analyses, the quality of pooled results is 
dependent on the quality of the data. A major limitation 
of this review is the lack of RCTs in the literature. As 
anticipated, in the observational studies, there was sig-
nifi cant selection bias. Only one study had matched 
cohorts based on patient age, sex, weight, and duct size. 
Th e treatment arms of other studies were determined 
by patient and surgeon preference. In general, studies 
reported that younger patients and patients with larger 
or morphologically diffi  cult PDAs were preferentially 
placed in the surgical arm as opposed to the catheter-
based arm. Furthermore, the largest study in the meta-
analysis excluded foreign nationals and patients with 
large ducts at the time of catheterization/operation. 15 Even 
excluding these patients, the loss to follow-up was 30%.  
 In addition, pooled studies vary in the types of surgical 
therapies and catheter-based therapies. Patients treated 
with VATS were combined with those treated by thora-
cotomy, and the various types of catheter-based therapies 
were combined. Th us, if a particular approach within 
one of these categories is significantly more or less 
superior, this will not be apparent in our results. For 
the primary outcome of need for reintervention, study 
heterogeneity was low, but for complication rates, there 
was moderate heterogeneity, limiting the interpretation 
of the results. 
 Because the data in these studies span  . 20 years, the 
results refl ect, to some extent, the outcomes of historical 
devices and approaches. Only 20 of the 417 patients in 
the catheter-based treatment arm of the observational 
studies were treated with the Amplatzer occluder, the 
device used most worldwide. 24,27,36,37 A study by 
Ghasemi et al 9 compared patients who had catheter-
based occlusion of their PDAs with patients treated with 
a variety of devices, including Gianturco coils, fl ipper 
coils, the Amplatzer occluder, and Nit Occlud coils. 
Patients treated by Gianturco and fl ipper coils had 
increased residual shunting compared with those treated 
with either the Amplatzer occluder or the Nit Occlud 
coils. Th ere were no mortalities, and major complica-
tions ranged from 10.9% (Gianturco coils) to 0.7% 
(Amplatzer occluder). An additional study of children 
with PDAs occluded with either the Amplatzer occluder 
or fl ipper coils had no mortality and low morbidity 
rates in both groups; however, the Amplatzer group 
had fewer reinterventions. 6 
 Conclusions 
 Closure of the nonpremature pediatric PDA using sur-
gical therapies is associated with lower reintervention 
rates. Whether this comes at a cost of greater complica-
tions is unclear. Th is meta-analysis did not include 
premature infants and, thus, the results should not be 
generalized to this patient population. VATS for occlu-
sion of PDAs presents an attractive alternative to open 
surgical ligation in the appropriately selected patient. 
However, few studies have compared VATS with catheter-
based therapies, specifi cally the Amplatzer occluder. 
With the evolution of surgical and catheter-based tech-
niques, more large-scale, randomized studies must be 
carried out comparing VATS to catheter-based therapy 
using the Amplatzer occluder and other new devices. 
Studies should further elucidate the optimal treatment 
strategy for occluding PDAs in specifi c patient popula-
tions based on age, size, and the morphology of the 
PDA. 
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